ODP083 Burosumab Treatment for Fibrous dysplasia/McCune-Albright Syndrome with Severe Spine Deformity

por Sato, Tetsuhiko, Azuma, Yoshinori, Tauchi, Ryoji, Matsushita, Masaki, Ozone, Chikafumi
Publicado 2022

The Pituitary Is a Candidate Organ That Modulates Circulating Klotho Levels

por Sato, Tetsuhiko, Komaba, Hirotaka, Nagatani, Tetsuya, Watanabe, Tadashi, Kishida, Yugo, Fukagawa, Masafumi
Publicado 2018

Predictors of Bone Mineral Density Improvement after Parathyroidectomy for Secondary Hyperparathyroidism: A Retrospective Single-Center Analysis

por Okada, Manabu, Tominaga, Yoshihiro, Tomosugi, Toshihide, Hiramitsu, Takahisa, Ichimori, Toshihiro, Sato, Tetsuhiko
Publicado 2021

A Possible Advantage of Glucagon-Like Peptide 1 Receptor Agonist in Kidney Transplant Recipients With Type 2 Diabetes

por Sato, Tetsuhiko, Ohara, Emi, Ozone, Chikafumi, Okazaki, Mikako, Fuse, Sachiho, Sasaki, Rie, Azuma, Yoshinori
Publicado 2021

Persistent hyperparathyroidism after preemptive kidney transplantation

por Okada, Manabu, Sato, Tetsuhiko, Hasegawa, Yuki, Futamura, Kenta, Hiramitsu, Takahisa, Ichimori, Toshihiro, Goto, Norihiko, Narumi, Shunji, Takeda, Asami, Watarai, Yoshihiko
Publicado 2023

Disrupted tubular parathyroid hormone/parathyroid hormone receptor signaling and damaged tubular cell viability possibly trigger postsurgical kidney injury in patients with advance...

por Sato, Tetsuhiko, Kikkawa, Yamato, Yamamoto, Suguru, Tanaka, Yusuke, Kazama, Junichiro J, Tominaga, Yoshihiro, Ichimori, Toshihiro, Okada, Manabu, Hiramitsu, Takahisa, Fukagawa, Masafumi
Publicado 2019

Elevated parathyroid hormone one year after kidney transplantation is an independent risk factor for graft loss even without hypercalcemia

por Okada, Manabu, Tominaga, Yoshihiro, Sato, Tetsuhiko, Tomosugi, Toshihide, Futamura, Kenta, Hiramitsu, Takahisa, Ichimori, Toshihiro, Goto, Norihiko, Narumi, Shunji, Kobayashi, Takaaki, Uchida, Kazuharu, Watarai, Yoshihiko
Publicado 2022